PH14927A - Sustained release formulation - Google Patents

Sustained release formulation

Info

Publication number
PH14927A
PH14927A PH18224A PH18224A PH14927A PH 14927 A PH14927 A PH 14927A PH 18224 A PH18224 A PH 18224A PH 18224 A PH18224 A PH 18224A PH 14927 A PH14927 A PH 14927A
Authority
PH
Philippines
Prior art keywords
sustained release
release formulation
formulation
sustained
release
Prior art date
Application number
PH18224A
Other languages
English (en)
Inventor
Prabhakar Ranchhordas Sheth
Jacques Levon Tosso Tossounian
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH14927A publication Critical patent/PH14927A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH18224A 1975-03-17 1976-03-29 Sustained release formulation PH14927A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (1)

Publication Number Publication Date
PH14927A true PH14927A (en) 1982-01-29

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
PH18224A PH14927A (en) 1975-03-17 1976-03-29 Sustained release formulation

Country Status (21)

Country Link
JP (1) JPS51115910A (ko)
AR (1) AR222624A1 (ko)
AT (1) AT353415B (ko)
AU (1) AU505355B2 (ko)
CA (1) CA1073358A (ko)
CH (1) CH630257A5 (ko)
DD (1) DD124102A5 (ko)
DE (1) DE2611041A1 (ko)
DK (1) DK148344C (ko)
ES (1) ES446075A1 (ko)
FR (1) FR2304354A1 (ko)
GB (1) GB1546448A (ko)
GR (1) GR60341B (ko)
IE (1) IE43083B1 (ko)
LU (1) LU74558A1 (ko)
MC (1) MC1101A1 (ko)
NL (1) NL190313C (ko)
NZ (1) NZ180321A (ko)
PH (1) PH14927A (ko)
PT (1) PT64907B (ko)
SE (1) SE433804B (ko)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
NL8600161A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
HU197201B (en) * 1985-10-01 1989-03-28 Sandoz Ag Process for producing oral pharmaceutical compositions of controlled solubility of the active components
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
DK0522128T3 (da) * 1991-01-30 1996-02-26 Wellcome Found Vanddispergerbare tabletter indeholdende acyclovir
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
CA2107678A1 (en) * 1991-04-08 1992-10-09 Kouichi Nakamichi Capsule
EP0632720B1 (en) * 1992-03-25 1998-11-11 Depomed Systems, Inc. Hydroxyethylcellulose-based sustained-release oral drug dosage froms
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
CA2175225C (en) * 1993-10-29 2004-09-21 Keith Graeme Hutchison Gelatin capsule fill able to foam
BR9407916A (pt) * 1993-10-29 1996-11-26 Reckitt & Colmann Prod Ltd Produto farmacêutico e processo para tratamento de esofagite de refluxo gastrite ou úlcera péptica
EP0759745A4 (en) * 1994-05-13 1997-11-19 Smithkline Beecham Corp METHOD AND COMPOSITION FOR INCREASING FIXATION OF CALCIUM
JPH10509981A (ja) * 1994-12-01 1998-09-29 サイバス ファーマシューティカル，インコーポレイティド 高等植物から得られうる粉末状親水コロイドゴムを用いる持効性薬剤送出
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (ko) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Also Published As

Publication number Publication date
IE43083L (en) 1976-09-17
GR60341B (en) 1978-05-17
NL7602776A (nl) 1976-09-21
GB1546448A (en) 1979-05-23
DD124102A5 (ko) 1977-02-02
AU1204976A (en) 1977-09-22
NL190313B (nl) 1993-08-16
CA1073358A (en) 1980-03-11
CH630257A5 (en) 1982-06-15
DE2611041A1 (de) 1976-10-14
ES446075A1 (es) 1977-09-16
FR2304354B1 (ko) 1979-04-27
PT64907A (fr) 1976-04-01
ATA192276A (de) 1979-04-15
NL190313C (nl) 1994-01-17
JPS51115910A (en) 1976-10-13
AR222624A1 (es) 1981-06-15
SE7603325L (sv) 1976-09-18
FR2304354A1 (fr) 1976-10-15
PT64907B (fr) 1978-03-24
NZ180321A (en) 1978-06-20
IE43083B1 (en) 1980-12-17
DE2611041C2 (ko) 1988-06-09
AU505355B2 (en) 1979-11-15
SE433804B (sv) 1984-06-18
JPS638084B2 (ko) 1988-02-19
MC1101A1 (fr) 1977-02-04
AT353415B (de) 1979-11-12
LU74558A1 (ko) 1977-09-27
DK148344B (da) 1985-06-17
DK148344C (da) 1985-11-04
DK113676A (da) 1976-09-18

Similar Documents

Publication Publication Date Title
PH14927A (en) Sustained release formulation
AU498744B2 (en) Release agent
JPS51144723A (en) Antiitumor agent
JPS51122091A (en) Antiibacterial agent
JPS5214798A (en) Antiibacterial agent
HK10881A (en) Gelling agents
JPS525787A (en) Antiibacterial agent
JPS5261231A (en) Antiitumor agent
JPS51112527A (en) Antiivirus agent
GB1555009A (en) Cluctch release mechanisms
AU1306576A (en) Pharmaceutical formulation
JPS51119248A (en) Position monitor
ZA766967B (en) Smell-removing agent
JPS5268195A (en) Antiibacterial agent
ZA76829B (en) Tablet formulation
JPS5253844A (en) Novel antiifertile agent
JPS5263186A (en) Clouddproofing agents
JPS5275677A (en) Releasing agent
ZA761305B (en) Sustained release formulation
JPS527420A (en) Antimelancholia agent
JPS51112447A (en) Antiiscale agent
JPS5253845A (en) Novel antiifertile agent
GB1539288A (en) Heat-sensitising agents
JPS5265290A (en) Antiibacterial agent
JPS5246094A (en) Antiibacterial agent

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 15

AT Record of annual fee payments

Year of fee payment: 16